and hence in these studies the mice were not screened according to sex.
Organism. The challenge organism was the penicillin-resistant Staphylococcus aureus Original, a strain maintained in our laboratories for years. It was preserved in the lyophilized form at 0 C, and stock cultures were grown on Staphylococcus Medium 110 (Difco) slants once in every 6 months. For routine experiments, the inoculum was prepared from 24-hr cultures on the slants at 37 C. The cells were washed and suspended in physiological saline (TC Tyrode Solution, Difco). We used 0.5 ml of a suspension of twice-washed cells adjusted to give a 70% transmission on a nephelometer (2.6 X 108 organisms) which caused 80 to 90% mortality in 5 days after subcutaneous challenge in the groin. Only rarely (Table 5 ) was a lower mortality obtained.
MUKKADA, NUTINI, AND COOK periments was prepared from freshly obtained brain by using a modification of the method described by Nutini and Lynch (10) . The brain was cleared of the membrane (pia mater), ground, and extracted with an equal amount of distilled water for 20 to 24 hr at 2 to 4 C. The water extract was then deproteinized with requisite amounts of ethyl alcohol to give a final concentration of 80%. The precipitated proteins were discarded, and the filtrate was concentrated in vacuo. The concentrate was mixed with Celite and further concentrated over a steam bath in open dishes. It was then filtered repeatedly through Celite pads with alternate refrigeration until a clear golden product was obtained. The pH of the extract was adjusted to 7.0, and the extract was sterilized by Seitz filtration and stored under refrigeration in sterile serum bottles. The dry weight of each batch was determined separately.
Homocarnosine sulfate, --aminobutyric acid, Lhistidine, sphingomyelin, and phrenosin were purchased from Nutritional Biochemicals Corporation, Cleveland, Ohio, and aqueous solutions were injected subcutaneously in dosages indicated in each experiment. In some instances homocarnosine from other sources was also used.
RESULTS
Brain extract and homocarnosine: prophylactic treatment. A few initial experiments were done to confirm the prophylactic effect of brain extract in Swiss albino mice, which had not been used in the earlier work, and to compare it with homocarnosine. Two sphingolipids, sphingomyelin and phrenosin, known to be present in brain were also included in these experiments, since they were reported to be effective in C3H mice (N. J layer chromatography. These samples often showed reduced activity and were excluded from the present report. Subsequently we have synthesized the pure compound which shows uniformity of antistaphylococcal behavior within the limits of biological variation. To minimize possible variation in these experiments, we chose an arbitrary dose of 5 mg per mouse which appears to be well above the minimal effective dose. Even 1.5 mg per mouse (approximately 60 to 75 mg/kg) gave comparable protection (Table   3 ). The data in Table 3 were not intended to establish a dose response relationship or a minimal effective dose, but only to insure that we were working with an unquestionably effective dose. Subsequent experiments were designed to ascertain the duration of protection given by homocarnosine. For each experiment, 50 mice were treated with homocarnosine sulfate (5 mg per animal) in three subcutaneous injections as before. They were divided into five groups and each group was challenged with S. aureus at weekly intervals, with a fresh set of controls each time. The first group was challenged 24 hr after the last treatment. Although there is a slight drop in the degree of protection with the lapse of time, homocarnosine by itself is able to protect mice against the infection at least up to a period of 1 month (Table 4 ). Table 5 shows the results of an experiment in which five groups of 10 animals each were treated with homocarno- Peptide and its component amino acids. Previous work (15) showed that whereas homocarnosine protected animals against infections, its components, L-histidine and y-aminobutyric acid, by themselves were ineffective in Swiss mice with the dosage schedule used. Therefore experiments were undertaken to determine (i) the effect of a mixture of the two component amino acids in equimolar concentrations and (ii) the effect of a combination of homocarnosine with any one of the components. Table 6 shows the results of these experiments in which the various substances were administered in three divided doses as before. These data, though confirming the antistaphylococcal activity of homocarnosine, indicated that its components either singly or in combination were ineffective under these conditions, and, indeed, either component appeared to diminish the effectiveness of homocarnosine when administered with it. Experiments now underway indicate that y-aminobutyric acid may exhibit activity when a different dosage schedule is employed. These experiments will be reported later.
Resistance to rechallenge. In view of the fre-VOL. 18, 1969 Effects of homocarnosine on S. aureus in vitro. The results of in vivo experiments prompted a study of possible direct effects of homocarnosine on the infecting organism itself. Since a detailed treatment of these studies will form the basis of a separate communication, the present discussion will be restricted to some of the main findings with regard to the effects on growth, pigmentation, fermentation of mannitol, gelatin liquefaction, and the production of coagulase and deoxyribonuclease. Homocarnosine was incorporated into the respective media at a concentration of 0.2 mg/ml. For chromogenesis and coagulase, Staphylococcus Medium 110 was used. Phenol Red Mannitol Agar (Difco) and Nutrient Gelatin (Difco) served as test media for mannitol fermentation and gelatin liquefaction, respectively. DNase Test Agar (Difco) was used for deoxyribonuclease production. Our results showed that, when incorporated into a growth medium, homocarnosine did not in any way alter the basic characteristics of the organisms, nor did it affect the rate of growth. Filter paper discs soaked in homocarnosine solution (1.0 mg/ml) placed on plates inoculated with S. aureus did not show any inhibition or enhancement of growth in their vicinity. Even when the same clone was continuously exposed to homocarnosine by maintenance on nutrient agar containing homocarnosine sulfate (1% by weight) for 20 subcultures at intervals of 3 days each, no significant changes were noticed. There was some indication of a loss of coagulase production after 10 subcultures on this medium but chromogenesis, mannitol fermentation, gelatin liquefaction, and deoxyribonuclease production remained unchanged. Similar experiments were also done with brain extract and "immune" serum by incorporating them into growth media, and the results were similar to those obtained with homocarnosine. These did not affect coagulase production either. However, brain extract and "immune" serum stimulated growth in vitro, the latter being much more stimulatory than the former. DISCUSSION
Although the physiological function of homocarnosine is still speculative, the present studies have shown its ability to induce resistance to staphylococcal infections in mice. Tanaka et al. (15, 16) reported that the dipeptides, L-carnosine, homocarnosine and anserine, possess antistaphylococcal properties in C3H mice and proposed that the protective value of brain extract may in part be ascribed to these peptides or compounds related to them. Although we confirmed the antistaphylococcal property of homocarnosine, we did not find such activity for carnosine or anserine in Swiss albino mice, except perhaps in the early stages of infection, under the conditions of assay (15) . The sphingolipids, sphingomyelin and phrenosin, were also essentially ineffective, although they, too, had displayed activity in C3H mice (N. J. Berberich, Jr., Ph 
